title: Letter to the editor: "Immunosuppressive drug therapy--biopharmaceutical challenges and remedies".
authors.affiliation: a Intensive Care Medicine, Department of Intensive Care and National Poisons Information Center, University Medical Center Utrecht , Utrecht , The Netherlands.|b Division of Anesthesiology, Intensive Care and Emergency Medicine, Department of Intensive Care and National Poisons Information Center, University Medical Center Utrecht , B 00.118, P.O. Box 85500, 3508 GA , Utrecht , The Netherlands.
authors.forename: M A
authors.initials: MA
authors.lastname: Sikma
authors.affiliation: c Clinical Pharmacy, Department of Clinical Pharmacy, University Medical Center Utrecht , Utrecht , The Netherlands.
authors.forename: E M
authors.initials: EM
authors.lastname: van Maarseveen
authors.affiliation: d Intensive Care Medicine, Department of Intensive Care, University Medical Center Utrecht , Utrecht , The Netherlands.
authors.forename: D W
authors.initials: DW
authors.lastname: Donker
authors.affiliation: e Intensive Care Medicine and Clinical Toxicology, National Poisons Information Center and Department of Intensive Care, University Medical Center Utrecht and Institute for Risk Assessment Sciences, Utrecht University , Utrecht , The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Meulenbelt
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D000818:Animals; D016503:Drug Delivery Systems; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D007166:Immunosuppressive Agents